BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leitner GC, Vogelsang H. Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults. World J Gastrointest Pharmacol Ther 2016; 7(1): 5-20 [PMID: 26855808 DOI: 10.4292/wjgpt.v7.i1.5]
URL: https://www.wjgnet.com/1007-9327/full/v7/i1/5.htm
Number Citing Articles
1
Sundus Bhatti, Imad Jaafar, Hamza Hassan, Hadi Atassi, Abigail Stocker, Michael Hughes, Christina Pinkston, Gerald Dryden, Thomas Abell. Effects of Gastric Neuromodulation on Crohn’s Disease in Patients With Coexisting Symptoms of GastroparesisNeuromodulation: Technology at the Neural Interface 2020; 23(8): 1196 doi: 10.1111/ner.13118
2
Sihem Ait‐Oudhia, Yi Ting (Kayla) Lien, Sumit Basu, Lawrence Lesko, Stephan Schmidt. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune‐Mediated Inflammatory Diseases2019; : 209 doi: 10.1002/9781119289234.ch10
3
Mariana Ferreira-Duarte, Tiago Rodrigues-Pinto, Teresa Sousa, Miguel A. Faria, Maria Sofia Rocha, Daniela Menezes-Pinto, Marisa Esteves-Monteiro, Fernando Magro, Patrícia Dias-Pereira, Margarida Duarte-Araújo, Manuela Morato. Interaction between the Renin–Angiotensin System and Enteric Neurotransmission Contributes to Colonic Dysmotility in the TNBS-Induced Model of ColitisInternational Journal of Molecular Sciences 2021; 22(9): 4836 doi: 10.3390/ijms22094836
4
Christophe Passot, Denis Mulleman, Theodora Bejan-Angoulvant, Alexandre Aubourg, Stephanie Willot, Thierry Lecomte, Laurence Picon, Philippe Goupille, Gilles Paintaud, David Ternant. The underlying inflammatory chronic disease influences infliximab pharmacokineticsmAbs 2016; 8(7): 1407 doi: 10.1080/19420862.2016.1216741
5
Taraneh Mousavi, Shokoufeh Hassani, Maryam Baeeri, Mahban Rahimifard, Faezeh Vakhshiteh, Mahdi Gholami, Elmira Ghafour-Broujerdi, Mohammad Abdollahi. Comparison of the safety and efficacy of fingolimod and tofacitinib in the zebrafish model of colitisFood and Chemical Toxicology 2022; 170: 113509 doi: 10.1016/j.fct.2022.113509
6
Emre Gerçeker, Hakan Yüceyar, Elmas Kasap, Ufuk Demirci, Burcu Ceren Ekti, İsmet Aydoğdu, Mine Miskioğlu. Treatment of inflammatory bowel disease by leukocytapheresisTransfusion and Apheresis Science 2017; 56(3): 421 doi: 10.1016/j.transci.2017.03.016
7
Daniel Ferri, Pablo Gaviña, Margarita Parra, Ana M. Costero, Jamal El Haskouri, Pedro Amorós, Virginia Merino, Adrián H. Teruel, Félix Sancenón, Ramón Martínez-Máñez. Mesoporous silica microparticles gated with a bulky azo derivative for the controlled release of dyes/drugs in colonRoyal Society Open Science 2018; 5(8): 180873 doi: 10.1098/rsos.180873
8
Mohamed Salla, Jimmy Guo, Harshad Joshi, Marilyn Gordon, Hitesh Dooky, Justine Lai, Samantha Capicio, Heather Armstrong, Rosica Valcheva, Jason R. B. Dyck, Aducio Thiesen, Eytan Wine, Levinus A. Dieleman, Shairaz Baksh. Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive InflammationInternational Journal of Molecular Sciences 2023; 24(6): 5967 doi: 10.3390/ijms24065967
9
Jisu Kim, Suji Baek, Nan Hee Choi, Seung-Hae Kwon, So Hui Lee, Kang Pa Lee. Protective Effect of Korean Hedyotis diffusa Extract Against Dextran Sulfate Sodium-induced Colitis in MiceInternational Journal of Pharmacology 2020; 16(4): 291 doi: 10.3923/ijp.2020.291.297
10
Hyun Kyeong Yoo, Han Geul Byun, Flavio Caprioli, Mathurin Fumery, Laurent Peyrin-Biroulet, Subramanian Sreedhar, James Potter, Minyoung Jang. Budget impact analysis of the subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in the Big-5 European (E5) countriesBMC Health Services Research 2022; 22(1) doi: 10.1186/s12913-022-08683-y
11
Ali Sen, Meral Yuksel, Gizem Bulut, Leyla Bitis, Feriha Ercan, Nagehan Ozyilmaz-Yay, Ozben Akbulut, Hamit Cobanoğlu, Sevil Ozkan, Goksel Sener. Therapeutic Potential ofMyrtus communisSubsp.communisExtract Against Acetic ACID-Induced Colonic Inflammation in RatsJournal of Food Biochemistry 2017; 41(1): e12297 doi: 10.1111/jfbc.12297
12
Jie Ren, Dong Yan, Yichun Wang, Jiaojiao Zhang, Min Li, Wancheng Xiong, Xueqian Jing, Puze Li, Weidong Zhao, Xiwen Xiong, Minna Wu, Genshen Zhong. Inhibitor of Differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis by Inhibiting NF-κB Activation in NeutrophilsFrontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.760999
13
M.M. Chulkina, A.V. Pichugin, R.I. Ataullakhanov. Pharmaceutical grade synthetic peptide Thr-Glu-Lys-Lys-Arg-Arg-Glu-Thr-Val-Glu-Arg-Glu-Lys-Glu ameliorates DSS-induced murine colitis by reducing the number and pro-inflammatory activity of colon tissue-infiltrating Ly6G+ granulocytes and Ly6C+ monocytesPeptides 2020; 132: 170364 doi: 10.1016/j.peptides.2020.170364
14
Semih KALYON, Yasemin GÖKDEN, Fırat OYMAN. A new biological marker in inflammatory bowel disease: Pentraxin 3Journal of Surgery and Medicine 2020; 4(10): 875 doi: 10.28982/josam.791156
15
Kendra J. Kamp, Kelly Brittain. Factors that Influence Treatment and Non-treatment Decision Making Among Individuals with Inflammatory Bowel Disease: An Integrative ReviewThe Patient - Patient-Centered Outcomes Research 2018; 11(3): 271 doi: 10.1007/s40271-017-0294-0
16
Allison L. Goetsch, Dana Kimelman, Teresa K. Woodruff. Fertility Preservation and Restoration for Patients with Complex Medical Conditions2017; : 249 doi: 10.1007/978-3-319-52316-3_15
17
Jayshree Mishra, Madyson Stubbs, Longxiang Kuang, Nitza Vara, Priyam Kumar, Narendra Kumar, Veedamali S. Subramanian. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic EngineeringMediators of Inflammation 2022; 2022: 1 doi: 10.1155/2022/9621668
18
Cintia M. S. Cereda, Giovana R. Tofoli. Biotechnology Applied to Inflammatory DiseasesInterdisciplinary Biotechnological Advances 2023; : 287 doi: 10.1007/978-981-19-8342-9_13
19
Shuzan Ali Mohammed, Azza Elbaramawy, Somia Hassan Abd‐Allah, Adel Elkholy, Nashwa Ibrahim Elsayed, Samia Hussein. Therapeutic potentials of mesenchymal stem cells in the treatment of inflammatory bowel disease in ratsJournal of Biochemical and Molecular Toxicology 2024; 38(1) doi: 10.1002/jbt.23532
20
Elżbieta Kamysz, Maciej Sałaga, Małgorzata Sobocińska, Artur Giełdoń, Jakub Fichna. Anti-Inflammatory Effect of Novel Analogs of Natural Enkephalinase Inhibitors in a Mouse Model of Experimental ColitisFuture Medicinal Chemistry 2016; 8(18): 2231 doi: 10.4155/fmc-2016-0156
21
J.L. Cabriada, I. Rodríguez-Lago. Granulocitoaféresis en 2017. Puesta al díaEnfermedad Inflamatoria Intestinal al Día 2017; 16(2): 62 doi: 10.1016/j.eii.2016.12.001
22
Nina Worel, Behrouz Mansouri Taleghani, Erwin Strasser. Recommendations for Therapeutic Apheresis by the Section “Preparative and Therapeutic Hemapheresis” of the German Society for Transfusion Medicine and ImmunohematologyTransfusion Medicine and Hemotherapy 2019; 46(6): 394 doi: 10.1159/000503937
23
Matteo Martinato, Elena Boffo, Greta Lorenzon, Eleonora Monaco, Clara Iervolino, Rosanna Irene Comoretto, Edoardo Vincenzo Savarino, Dario Gregori. Nursing Interventions Targeting Fatigue in Inflammatory Bowel Disease: A Systematic ReviewGastrointestinal Disorders 2024; 6(3): 706 doi: 10.3390/gidisord6030047
24
Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi. Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD)Expert Review of Clinical Pharmacology 2021; 14(7): 865 doi: 10.1080/17512433.2021.1925108
25
Yi Xu, David J. Baylink, Huynh Cao, Jeffrey Xiao, Maisa I. Abdalla, Samiksha Wasnik, Xiaolei Tang. Inflammation- and Gut-Homing Macrophages, Engineered to De Novo Overexpress Active Vitamin D, Promoted the Regenerative Function of Intestinal Stem CellsInternational Journal of Molecular Sciences 2021; 22(17): 9516 doi: 10.3390/ijms22179516
26
Kazuhiko Ono, Satoshi Nimura, Yuko Hideshima, Kazuki Nabeshima, Manabu Nakashima. Orally administered sodium 4‑phenylbutyrate suppresses the development of dextran sulfate sodium‑induced colitis in miceExperimental and Therapeutic Medicine 2017;  doi: 10.3892/etm.2017.5251
27
Xiaoyi Liu, Shuai Chen, Huijuan Liu, Jiao Xie, K. M. Faridul Hasan, Qibing Zeng, Shaofeng Wei, Peng Luo. Structural properties and anti-inflammatory activity of purified polysaccharides from Hen-of-the-woods mushrooms (Grifola frondosa)Frontiers in Nutrition 2023; 10 doi: 10.3389/fnut.2023.1078868
28
Faisal Inayat, Waqas Ullah, Qulsoom Hussain, Khurram Shafique. Crohn’s disease presenting as gastric outlet obstruction: a therapeutic challenge?BMJ Case Reports 2017; : bcr-2016-218181 doi: 10.1136/bcr-2016-218181
29
Carolina Martins Lázaro, Carolina C. de Oliveira, Alessandra Gambero, Thalita Rocha, Cintia Maria Saia Cereda, Daniele Ribeiro de Araújo, Giovana Radomille Tofoli. Evaluation of Budesonide–Hydroxypropyl-β-Cyclodextrin Inclusion Complex in Thermoreversible Gels for Ulcerative ColitisDigestive Diseases and Sciences 2020; 65(11): 3297 doi: 10.1007/s10620-020-06075-y
30
Karen Dubois-Camacho, Payton A Ottum, Daniel Franco-Muñoz, Marjorie De la Fuente, Alejandro Torres-Riquelme, David Díaz-Jiménez, Mauricio Olivares-Morales, Gonzalo Astudillo, Rodrigo Quera, Marcela A Hermoso. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biologyWorld Journal of Gastroenterology 2017; 23(36): 6628-6638 doi: 10.3748/wjg.v23.i36.6628
31
J. Winny Yun, Alireza Minagar, J. Steven Alexander. Inflammatory Disorders of the Nervous System2017; : 1 doi: 10.1007/978-3-319-51220-4_1
32
Daniel Muthas, Anna Reznichenko, Clare A. Balendran, Gerhard Böttcher, Ib Groth Clausen, Carina Kärrman Mårdh, Tomas Ottosson, Mohib Uddin, Thomas T. MacDonald, Silvio Danese, Mark Berner Hansen. Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implicationsScandinavian Journal of Gastroenterology 2017; 52(2): 125 doi: 10.1080/00365521.2016.1235224
33
Claire J. Han, Margaret M. Heitkemper. Handbook of Sleep Disorders in Medical Conditions2019; : 371 doi: 10.1016/B978-0-12-813014-8.00017-2
34
K. Balendran, S. Udumalagala, N. M. M. Nawaraththne. Pyloric stenosis as a manifestation of isolated gastric Crohn’s disease responding to intralesional steroid injection and balloon dilation: a case reportJournal of Medical Case Reports 2019; 13(1) doi: 10.1186/s13256-019-2272-8
35
González-Ramírez Adriana Estrella, González-Trujano María Eva, Hernandez-Leon Alberto, Valle-Dorado María Guadalupe, Carballo-Villalobos Azucena, Orozco-Suárez Sandra, Alvarado-Vásquez Noé, López-Muñoz Francisco Javier. Limonene from Agastache mexicana essential oil produces antinociceptive effects, gastrointestinal protection and improves experimental ulcerative colitisJournal of Ethnopharmacology 2021; 280: 114462 doi: 10.1016/j.jep.2021.114462
36
Mahmoud Mosli, Sultan Alfaer, Turki Almalaki, Abdulrahman Albeshry, Saja Aljehani, Bashaer Alshmrani, Zaineb Habib, Hani Jawa, Yousif Qari. Baseline risk assessment of patients with ulcerative colitis: does initial treatment selection influence outcomes?European Journal of Gastroenterology & Hepatology 2019; 31(1): 80 doi: 10.1097/MEG.0000000000001249
37
Farah Yasmin, Hala Najeeb, Unaiza Naeem, Abdul Moeed, Thoyaja Koritala, Salim Surani. Apheresis: A cell-based therapeutic tool for the inflammatory bowel diseaseWorld Journal of Clinical Cases 2022; 10(21): 7195-7208 doi: 10.12998/wjcc.v10.i21.7195